CTHRC1 as a Novel Regulatory Target of Type I Collagen Synthesis via ATF4 in Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by excessive deposition of extracellular matrix, primarily type I collagen. This study investigates the role of Collagen triple helix repeat containing 1 (CTHRC1) in pulmonary fibrosis. Analysis of public databases and validation in mouse models revealed that CTHRC1 expression is significantly upregulated and strongly correlates with type I collagen. Single-cell RNA sequencing and immunofluorescence supported a close association between CTHRC1 and myofibroblasts in fibrotic lungs. In vitro, CTHRC1 knockdown in NIH3T3 fibroblasts attenuated TGF-β1-induced type I collagen production. Mechanistically, CTHRC1 silencing reduced phosphorylation of the TGF-β receptor I and its downstream effectors Smad2/3, accompanied by reduced protein expression of the transcription factor ATF4 and its target, the collagen synthesis enzyme PSAT1. These findings support a CTHRC1–TGF-β/Smad–ATF4/PSAT1 signaling model for type I collagen regulation, providing a basis for further investigation of CTHRC1 and the associated pathway as potential therapeutic targets in IPF.

Authors

Institutions

Publication Details

Journal
Molecules
Published
2026-11-12
DOI
https://doi.org/10.3390/molecules31224088
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

CTHRC1 as a Novel Regulatory Target of Type I Collagen Synthesis via ATF4 in Pulmonary Fibrosis

赵育桢, Juan Chen, Chenhong Shi, Rui Yan et al.
Molecules
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

CTHRC1 as a Novel Regulatory Target of Type I Collagen Synthesis via ATF4 in Pulmonary Fibrosis

赵育桢, Juan Chen, Chenhong Shi, Rui Yan, Ziyu Qiao, Yuhan Di, Yixuan Li, Yiran Zhang, Wen Zhang, Ran Bi, Yanan Sun
article en

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by excessive deposition of extracellular matrix, primarily type I collagen. This study investigates the role of Collagen triple helix repeat containing 1 (CTHRC1) in pulmonary fibrosis. Analysis of public databases and validation in mouse models revealed that CTHRC1 expression is significantly upregulated and strongly correlates with type I collagen. Single-cell RNA sequencing and immunofluorescence supported a close association between CTHRC1 and myofibroblasts in fibrotic lungs. In vitro, CTHRC1 knockdown in NIH3T3 fibroblasts attenuated TGF-β1-induced type I collagen production. Mechanistically, CTHRC1 silencing reduced phosphorylation of the TGF-β receptor I and its downstream effectors Smad2/3, accompanied by reduced protein expression of the transcription factor ATF4 and its target, the collagen synthesis enzyme PSAT1. These findings support a CTHRC1–TGF-β/Smad–ATF4/PSAT1 signaling model for type I collagen regulation, providing a basis for further investigation of CTHRC1 and the associated pathway as potential therapeutic targets in IPF.

MoleculesVol. 31(22)
Chinese PLA General Hospital (CN), China Agricultural University (CN)
China Association for Science and Technology, Ministry of Education of the People's Republic of China
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon